Stay updated on Arginase Inhibitor & Checkpoint Therapy in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Arginase Inhibitor & Checkpoint Therapy in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Arginase Inhibitor & Checkpoint Therapy in Solid Tumors Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3 on the site.
    Difference
    0.0%
    Check dated 2026-03-12T04:55:43.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Gastric cancer was added to the Conditions section. The page was updated to revision v3.4.2, and the prior government-funding lapse notice (v3.4.1) was removed.
    Difference
    0.3%
    Check dated 2026-02-11T16:22:39.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added an informational Notice banner about a lapse in government funding and updated to Revision: v3.4.1; the change does not modify study data or eligibility details.
    Difference
    0.3%
    Check dated 2026-02-04T10:50:54.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    UI/footer text updates include adding a 'Show glossary' control and standardizing capitalization for labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'. The revision label updated from v3.3.4 to v3.4.0.
    Difference
    0.1%
    Check dated 2026-01-28T06:19:19.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision line updated from v3.3.3 to v3.3.4 in the page footer. This appears to be a minor site version update with no visible changes to content or functionality.
    Difference
    0.0%
    Check dated 2026-01-14T02:57:21.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The new Locations section now lists Alabama, Arizona, District of Columbia, Maryland, Massachusetts, Michigan, Tennessee, and Texas. The former state-specific location entries were removed.
    Difference
    0.7%
    Check dated 2025-12-23T17:31:21.000Z thumbnail image

Stay in the know with updates to Arginase Inhibitor & Checkpoint Therapy in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Arginase Inhibitor & Checkpoint Therapy in Solid Tumors Clinical Trial page.